KelSie Biotech
Latest round
- Series A
Last raised
- May 2019
Total raised
- $5M
Investors
- 2
About KelSie Biotech
Founded in 2017 and headquartered in Englewood, US, KelSie Biotech, LLC focuses on developing enhanced drug delivery systems.KelSie Biotech specializes in innovative formulation services aimed at enhancing drug delivery through advanced technologies such as their Genesis CAN-BD formulation. Their core offerings include a range of delivery systems including deep lung delivery, nasal sprays, sublingual wafers, and topical applications. Each product is designed to address specific therapeutic needs, allowing for more effective administration of medications.KelSie Biotech's revenue model is structured around B2B interactions, focusing on partnerships and collaborations with pharmaceutical companies and research institutions. The firm engages in direct transactions for its formulation services, typically structured as project-based agreements or long-term partnerships based on specific client needs. The company is targeting expansion into new geographic regions, particularly in key markets across Asia, with plans to initiate this expansion by 2023. KelSie Biotech aims to enhance its product offerings and reach a broader client base through these strategic initiatives.
Who invested in KelSie Biotech
2 investors across 1 round
See all investors in KelSie Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 31, 2019
Amount
$5M
Investors
Questions about KelSie Biotech
Who invested in KelSie Biotech?
KelSie Biotech has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has KelSie Biotech raised?
KelSie Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did KelSie Biotech last raise money?
KelSie Biotech's most recent round on record is a Series A, in May 2019.
What does KelSie Biotech do?
Founded in 2017 and headquartered in Englewood, US, KelSie Biotech, LLC focuses on developing enhanced drug delivery systems.
Where is KelSie Biotech headquartered?
KelSie Biotech is headquartered in Englewood, US.
Which VCs invest in companies like KelSie Biotech?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at KelSie Biotech's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like KelSie Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.